Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation

Carcinogenesis

Volumn 15, Issue 8, 1994, Pages 1479-1486

  Himmelstein, Matthew W ^a   Turner, Max J ^a   Asgharian, Bahman ^a   Bond, James A ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; BUTADIENE DIEPOXIDE; CARCINOGEN; DICHLOROMETHANE; EPOXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARCINOGEN TESTING; CARCINOGENICITY; CONTROLLED STUDY; GAS CHROMATOGRAPHY; INHALATION; MALE; MASS SPECTROMETRY; METABOLIC ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ANIMAL; BUTADIENES; COMPARATIVE STUDY; EPOXY COMPOUNDS; IN VITRO; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028092965     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/15.8.1479     Document Type: Article

References (40)

1. Chemical Engineering News (1994) Top 50 chemical production rose modestly last year. Chem. Engng News, April 2, 12-16.
2. Environmental Protection Agency (1991) Preliminary draft list of categories and subcategories under Section 112 of the Clean Air Act. Fed. Reg., 56, 28548-28557.
3. Brunnemann, K.D., Kagan, M.R., Cox, J.E. and Hoffmann, D. (1990) Analysis of 1, 3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis, 11, 1863-1868.
4. Pelz, N., Dempster, A.M. and Shore, P.R. (1990) Analysis of low molecular weight hydrocarbons including 1, 3-butadiene in engine exhaust gases using an aluminum oxide porous-layer open-tubular fused-silica column. J. Chromatogr. Sci., 28, 230-235.
5. Meinhardt, T.J., Lemen, R.A., Crandall, M.S. and Young, R.J. (1982) Environmental epidemiologic investigation of the styrene-butadiene rubber industry: mortality patterns with discussion of the hematopoietic and lymphatic malignancies. Scand. J. Work Environ. Hlth, 8, 250-259.
6. International Agency for Research on Cancer (1992) Monographs on the Evaluation of Carcinogenic Risks to Humans, Occupational Exposures to Mists and Vapours from Strong Inorganic Acids; and Other Industrial Chemicals. Vol. 54, 1, 3-Butadiene. LARC, Lyon, France, pp. 237-285.
7. Divine, B.J. (1990) An update on mortality among workers at a 1, 3- butadiene facility-preliminary results. Environ. Hlth Perspect., 86, 119-128.
8. Health Effects Institute (1993) Research priorities for mobile air toxics: Research priorities to reduce uncertainties for 1, 3-butadiene. Hlth Effects Inst. Commun., 2, 44-66.
9. Huff, J.E., Melnick, R.L., Solleveld, H.A., Haseman, J.K., Powers, M. and Miller, R.A. (1985) Multiple organ carcinogenicity of 1, 3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science, 227, 548-549.
10. Melnick, R.L., Huff, J., Chou, B.J. and Miller, R.A. (1990) Carcinogenicity of 1, 3-butadiene in B6C3F1 mice at low exposure concentrations. Cancer Res., 50, 6592-6599.
11. Owen, P.E., Glaister, J.R., Gaunt, I.F. and Pullingcr, D.H. (1987) Inhalation toxicity studies with 1, 3-butadiene. III. Two year toxicity/carcinogenicity studies in rats. Am. Ind. Hyg. Assoc. J., 48, 407-413
12. de Meester, C., Poncelet, F., Roberfroid, M. and Merrier, M. (1978) Mutagenicity of butadiene and butadiene monoxide. Biochem. Biophys. Res. Commun., 80, 298-305.
13. de Meester, C., Poncelet, F., Roberfroid, M. and Merrier, M. (1980) The mutagenicity of butadiene towards Salmonella typhimurium. Toxicol. Lett., 6, 125-130.
14. Gervasi, P.G., Citti, L., Del Monte, M., Longo, V. and Benetti, D. (1985) Mutagenicity and chemical reactivity of epoxidic intermediates of the isoprene metabolism and other structurally related compounds. Mutat. Res., 156, 77-82.
15. Tice, R.R., Boucher, R., Luke, C.A. and Shelby, M.D. (1987) Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1, 3-butadiene. Environ. Mutagen., 9, 235-250.
16. Cunningham, M.J., Choy, W.N., Arce, G.T., Rickard, L.B., Vlachos, D.A., Kinney, L.A. and Sariff, A.M. (1986) In vivo sister chromatid exchange and micronucleus induction studies with 1, 3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagenesis, 1, 449-452.
17. International Agency for Research on Cancer (1976) Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man; Cadnium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics. Vol. 11, Diepoxybutane. IARC, Lyon, France, pp. 115-123.
18. Malvoisin, E. and Roberfroid, M. (1982) Hepatic microsomal metabolism of 1, 3-butadiene. Xenobiotica, 12, 137-144.
19. Bolt, H.M., Filser, J.G. and Stormer, F. (1984) Inhalation pharmacokinetics based on gas uptake studies V. Comparative pharmacokinetics of ethylene and 1, 3-butadiene in rats. Arch. Toxicol., 55, 213-218.
20. Schmidt, L. and Loeser, E. (1985) Species differences in the formation of butadiene monoepoxide from 1, 3-butadiene. Arch. Toxicol., 57, 222-225.
21. Kreiling, R., Laib, R.J., Filser, J.G. and Bolt, H.M. (1986) Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics. Arch. Toxicol., 58, 235-238.
22. Csanady, G.A., Guengerich, F.P. and Bond, J.A. (1992) Comparison of the biotransformation of 1, 3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice. Carcinogenesis, 13, 1143-1153.
23. Filser, J.G. and Bolt, H.M. (1984) Inhalation pharmacokinetics based on gas uptake studies VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1, 3-butadiene in rats. Arch. Toxicol, 55, 219-223.
24. Bond, J.A., Dahl, A.R., Henderson, R.F., Dutcher, J.S., Mauderly, J.L. and Bimbaum, L.S. (1986) Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol., 84, 617-627.
25. Dahl, A.R., Sun, J.D., Bimbaum, L.S., Bond, J. A., Griffith, W.C. Jr., Mauderly, J.L., Muggenburg, B.A., Sabourin, P.J. and Henderson, R.F. (1991) Toxicokinetics of inhaled 1, 3-butadiene in monkeys: Comparison to toxicokinetics in rats and mice. Toxicol. Appl. Pharmacol., 110, 9-19.
26. Kreiling, R., Laib, R.J., Filser, J.G. and Bolt, H.M. (1987) Inhalation pharmacokinetics of 1, 2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis. Arch. Toxicol. 61, 7-11.
27. National Institutes of Health (1985) Guide for the Care and Use of Laboratory Animals. US Department of Health and Human Services, Public Health Service, NIH Publication no. 86-23.
28. Cannon, W.C., Blanton, E.F. and McDonald, K.E. (1983) The flow past chamber: an improved nose-only exposure system for rodents. Am. Ind. Hyg. Assoc. J„ 44, 923-928.
29. Moss, O.R. (1993) Inhalation toxicology: Sampling techniques related to control of exposure atmospheres. In Willeke, K. and Baron, P.A. (eds), Aerosol Measurement: Principles, Techniques, and Applications. Van Nostrand Reinhold, New York, NY, Chapter 38, pp. 833-842.
30. Harms, P.J. and Ojeda, S.R. (1974) A rapid and simple procedure for chronic cannulation of the rat jugular vein. J. Appl. Physiol., 36, 391-392.
31. Bechtold, W.E., Medinsky, M.A. and Gerlach, R.F. (1988) The determination of a volatile gas, vinylidene fluoride, in blood during a nose-only exposure. J. Anal. Toxicol., 12, 62-66.
32. Sato, A. and Nakajima, T. (1979) Partition coefficients of some aromatic hydrocarbons and ketones in water, blood, and oil. Br. J. Ind. Med., 36, 231-234.
33. Medinsky, M.A., Leavens, T.L., Csanady, G.A., Gargas, M.L. and Bond, J.A. (1994) In vivo metabolism of butadiene by mice and rats: A comparison of physiological model predictions and experimental data. Carcinogenesis, 7, 1329-1340.
34. Code of Federal Regulations (1993) Protection of the Environment. Parts 136.2 and 136 Appendix B. U.S. National Archives & Record Administration, Washington D.C., July 7, 40, pp. 313, 569-571.
35. Mauderly, J.L. (1986) Respiration of F344 rats in nose-only exposure tubes. J. Appl. Toxicol., 6, 25-30.
36. Fairchild, G.A. (1972) Measurement of respiratory volume for virus retention studies in mice. Appl. Microbiol., 24, 812-818.
37. Evelo, C.T.A., Ooslendorp, J.G.M., ten Berge, W.F. and Borm, P.J.A. (1993) Physiologically based toxicokinetic modeling of 1, 3-butadiene lung metabolism in mice becomes more important at low doses. Environ. Hlth Perspect., 101, 496-502.
38. Kohn, M.C. and Melnick, R.L. (1993) Species differences in the production and clearance of 1, 3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical control. Carcinogenesis, 14, 619-628.
39. Johanson, G. and Filser, J.G. (1993) A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation. Arch. Toxicol., 93, 151-163.
40. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1, 2-epoxybutene, 1, 2, 3, 4- diepoxybutane and 3, 4-epoxy-1, 2-butanediol in cultured human lymphoblasts. Carcinogenesis, 15, 713-717.